Form 4: Abbott Labs Executive Sells Shares
Statement of Changes in Beneficial Ownership
Abbott Laboratories executive Elizabeth C. Cushman has reported the sale of company common shares.
Summary
- Elizabeth C. Cushman, EVP, GC, and Secretary of Abbott Laboratories, reported a transaction on June 27, 2026.
- Cushman sold 560 shares of common stock at a price of $94.12 per share.
- Following this transaction, Cushman beneficially owns 38,013 shares of Abbott Laboratories common stock directly.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the sale of shares by a key executive, although the amount is relatively small compared to total holdings.
Negatives
- An executive of Abbott Laboratories sold a portion of their holdings in the company's common stock.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a transaction of existing securities.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While a single sale by an executive does not necessarily indicate a negative outlook for Abbott Laboratories, it is a data point for investors to consider regarding insider sentiment.
Stakeholder Impact
- Shareholders may view the sale of shares by an executive with caution, potentially impacting short-term investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/27/2026 | Transaction date for the sale of common shares by Elizabeth C. Cushman. |
| 06/29/2026 | Date the statement of changes in beneficial ownership was signed. |
Keywords
Abbott Laboratories, ABT, Form 4, insider trading, stock sale, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.